| |
| |
|
| Insider
Information: |
Lachey Jennifer |
| Relationship: |
Chief Scientific Officer |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
95,100 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
95,100 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keros Therapeutics, Inc. |
KROS |
Chief Scientific Officer |
2022-07-15 |
95,100 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-02-11 |
4 |
OE |
$0.30 |
$1,590 |
D/D |
5,300 |
33,291 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-02-11 |
4 |
AS |
$62.85 |
$344,017 |
D/D |
(5,300) |
27,991 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-02-26 |
4 |
OE |
$0.11 |
$3,652 |
D/D |
33,200 |
61,191 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-03-11 |
4 |
AS |
$63.99 |
$341,750 |
D/D |
(5,300) |
61,191 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-03-11 |
4 |
OE |
$0.30 |
$1,590 |
D/D |
5,300 |
66,491 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-04-01 |
4 |
OE |
$0.11 |
$1,100 |
D/D |
9,996 |
71,187 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-04-12 |
4 |
OE |
$0.30 |
$1,590 |
D/D |
5,300 |
76,487 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-04-12 |
4 |
AS |
$59.10 |
$318,026 |
D/D |
(5,300) |
71,187 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-05-11 |
4 |
OE |
$0.30 |
$795 |
D/D |
2,650 |
73,837 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-05-11 |
4 |
AS |
$50.00 |
$132,500 |
D/D |
(2,650) |
71,187 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-05-13 |
4 |
OE |
$0.11 |
$834 |
D/D |
6,720 |
77,907 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-06-11 |
4 |
OE |
$0.30 |
$795 |
D/D |
2,650 |
80,557 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-06-11 |
4 |
AS |
$50.37 |
$135,087 |
D/D |
(2,650) |
77,907 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-06-24 |
4 |
OE |
$0.30 |
$1,950 |
D/D |
6,500 |
84,407 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-08-17 |
4 |
OE |
$0.30 |
$388 |
D/D |
1,293 |
85,700 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-11-04 |
4 |
OE |
$0.30 |
$3,180 |
D/D |
10,600 |
96,300 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-11-04 |
4 |
AS |
$50.00 |
$530,000 |
D/D |
(10,600) |
85,700 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-11-10 |
4 |
OE |
$0.30 |
$4,770 |
D/D |
15,900 |
101,600 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-11-10 |
4 |
AS |
$60.00 |
$954,000 |
D/D |
(15,900) |
85,700 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-11-11 |
4 |
OE |
$0.30 |
$1,590 |
D/D |
5,300 |
91,000 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-11-11 |
4 |
AS |
$58.73 |
$316,058 |
D/D |
(5,300) |
85,700 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-12-13 |
4 |
AS |
$50.11 |
$96,808 |
D/D |
(1,915) |
85,700 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-12-13 |
4 |
OE |
$0.30 |
$575 |
D/D |
1,915 |
87,615 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-12-15 |
4 |
OE |
$0.30 |
$221 |
D/D |
735 |
86,435 |
0 |
- |
|
| KROS |
Keros Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-12-15 |
4 |
AS |
$50.00 |
$36,750 |
D/D |
(735) |
85,700 |
0 |
- |
|
44 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
